Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2016)
Lantheus Holdings (LNTH) posted quarterly Depreciation & Amortization (CF) of -$5.4 million for Q4 2016, down 279.82% year-over-year from $3.0 million in Q1 2016, and down 240.55% quarter-over-quarter from $3.8 million in Q3 2016.
Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2016) Analysis & Trends
Lantheus Holdings (LNTH) has reported Depreciation & Amortization (CF) for 3 consecutive years, with -$5.4 million the latest figure, recorded in Q4 2016.
- In Q4 2016, Depreciation & Amortization (CF) fell 279.82% year-over-year to -$5.4 million; the TTM figure through Sep 2017 stood at -$5.4 million (down 133.33% YoY), while the FY2016 annual figure was $800000.0, down 95.93% from the prior year.
- Depreciation & Amortization (CF) fell to -$5.4 million in Q4 2016 per LNTH's latest filing, from $3.8 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $8.1 million in Q1 2015 and bottomed at -$5.4 million in Q4 2016.
- Historically, Depreciation & Amortization (CF) has averaged $3.5 million across 3 years, with a median of $4.2 million in 2014.
- Annual changes were most pronounced in 2015 — Depreciation & Amortization (CF) jumped 112.05% — and 2016, when it slumped 279.82%.
- Lantheus Holdings' Depreciation & Amortization (CF) stood at $4.2 million in 2014, then slipped by 28.77% to $3.0 million in 2015, then plunged by 279.82% to -$5.4 million in 2016.
- Business Quant data shows LNTH's Depreciation & Amortization (CF) at -$5.4 million in Q4 2016, $3.8 million in Q3 2016, and $4.8 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -5.40 Mn |
| Dec 31, 2016 | -5.40 Mn |
| Sep 30, 2016 | 3.84 Mn |
| Sep 30, 2016 | 3.84 Mn |
| Jun 30, 2016 | 4.77 Mn |
| Jun 30, 2016 | 4.77 Mn |
| Mar 31, 2016 | 4.59 Mn |
| Mar 31, 2016 | 4.59 Mn |
| Dec 31, 2015 | 3.00 Mn |
| Dec 31, 2015 | 3.00 Mn |
| Sep 30, 2015 | 4.08 Mn |
| Sep 30, 2015 | 4.08 Mn |
| Jun 30, 2015 | 4.45 Mn |
| Jun 30, 2015 | 4.45 Mn |
| Mar 31, 2015 | 8.12 Mn |
| Mar 31, 2015 | 8.12 Mn |
| Dec 31, 2014 | 4.22 Mn |
| Dec 31, 2014 | 4.22 Mn |
| Sep 30, 2014 | 4.93 Mn |
| Sep 30, 2014 | 4.93 Mn |